Industries

Medical Isotopes

Toutes les analyses de Medical Isotopes — 1 analyses.

44/100 76Buffett Hold Eckert & Ziegler SE: A Better Business, Not Yet a Better Price Eckert & Ziegler is a Berlin-based radioisotope specialist supplying generators, isotope products and CDMO services whose Medical segment is becoming the group's real profit engine as radiopharmaceutical oncology increasingly relies on lutetium-177 and actinium-225. 2025 revenue reached €312.0 million with Medical gross margin climbing to 49% and net financial position ending the year at €115.2 million, but 2026 guidance implies only about 3% revenue and adjusted-EBIT growth. Rating Hold: at €14.43 the stock already sits close to its conservative fair-value zone of €11.0–11.8, leaving minimal margin of safety for new buyers. Eckert & Ziegler SEEUZ · XETRAMedical Isotopes15 juillet 2026